These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1835324)

  • 1. Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to beta-agonist therapy.
    Shrestha M; O'Brien T; Haddox R; Gourlay HS; Reed G
    Ann Emerg Med; 1991 Nov; 20(11):1206-9. PubMed ID: 1835324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M
    Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
    Moayyedi P; Congleton J; Page RL; Pearson SB; Muers MF
    Thorax; 1995 Aug; 50(8):834-7. PubMed ID: 7570433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials.
    Stoodley RG; Aaron SD; Dales RE
    Ann Emerg Med; 1999 Jul; 34(1):8-18. PubMed ID: 10381989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD.
    Karpel JP; Kotch A; Zinny M; Pesin J; Alleyne W
    Chest; 1994 Apr; 105(4):1089-94. PubMed ID: 8162730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
    Rodrigo GJ; Rodrigo C
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1862-8. PubMed ID: 10852758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room.
    Rebuck AS; Chapman KR; Abboud R; Pare PD; Kreisman H; Wolkove N; Vickerson F
    Am J Med; 1987 Jan; 82(1):59-64. PubMed ID: 2879458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
    Colice GL
    Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial.
    Weber EJ; Levitt MA; Covington JK; Gambrioli E
    Chest; 1999 Apr; 115(4):937-44. PubMed ID: 10208189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
    Browne GJ; Trieu L; Van Asperen P
    Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD.
    Karpel JP; Pesin J; Greenberg D; Gentry E
    Chest; 1990 Oct; 98(4):835-9. PubMed ID: 2145136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
    Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
    Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP
    Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease.
    Bleecker ER; Britt EJ
    Am J Med; 1991 Oct; 91(4A):24S-27S. PubMed ID: 1835291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy.
    Patrick DM; Dales RE; Stark RM; Laliberte G; Dickinson G
    Chest; 1990 Aug; 98(2):295-7. PubMed ID: 2142915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.